2Wald NJ, Hackshaw AK. Cigarette smoking: an epidemiological overview. Br Med Bull, 1996,52:3-11.
3Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull, 1996, 52:12-21.
4World Health Organization. The tobacco epidemic: a global public health emergency. Tobacco Alert. April 1998. http: www. who.int/archives/tobalert/apr96/fulltext, htm.
5Hecht SS. Biochemistry, biology, and carcinogenicity of tobaccospecific N-Nitrosamines. Chem Res Toxico, 1998,11: 559-603.
6Hoffmann D, Brunnemann KD, Prokopczyk B, et al. Tobaccospecific N-nitrosamines and areca-derived N-nitrosamines:chemistry, biochemistry, carcinogenicity, and relevance to humans.J Toxicol Health, 1994,41:1-52.
7Zhou H, Calaf GM, Hei TK. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine,4-(methylnitrosamino)-1-( 3-pyridyl)-1-butanone. Int J Cancer,2003,106:821-826.
8Carmella SG, Borukhova A, Akerkar SA, et al. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidem Biomar Prev, 1997, 6:113-120.
9Hecht SS, Carmella SG, Ye M, et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res, 2002, 62:129-134.
10Finckh C, Atalla A, Nagel G, et al. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxy steroid dehydrogenase type 1 in human lung. Chem Biol Interact, 2001,130-132(1-3): 761-773.
